The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy

The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy

Dynamic changes in the blood-based biomarkers could be used as a prognostic biomarker in patients treated with immune checkpoint inhibitors (ICIs), although the data are limited. We evaluated the association between the neutrophil–lymphocyte ratio (NLR) and early NLR changes with survival in ICI-tre...

Full description

Bibliographic Details
Main Authors: Deniz Can Guven, Taha Koray Sahin, Enes Erul, Ibrahim Yahya Cakir, Enes Ucgul, Hasan Cagri Yildirim, Oktay Halit Aktepe, Mustafa Erman, Saadettin Kilickap, Sercan Aksoy, Suayib Yalcin
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Clinical Medicine
Subjects:
biomarker
cancer
Charlson Comorbidity Index
immunotherapy
neutrophil–lymphocyte ratio
NLR2-CEL
Online Access:https://www.mdpi.com/2077-0383/11/15/4523

Internet

https://www.mdpi.com/2077-0383/11/15/4523

Similar Items